These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [[Ear problems of Kaiser Wilhelm II: image of otology at the turn of the century]. Leithäuser D Laryngorhinootologie; 2000 Nov; 79(11):659-61. PubMed ID: 11138505 [No Abstract] [Full Text] [Related]
27. Temporal bone histopathology case of the month. First branchial cleft anomaly with an orifice in the bony external auditory canal accompanied by contralateral middle ear cholesteatoma. Ohki M; Baba Y; Ohata A Otol Neurotol; 2015 Feb; 36(2):e70-2. PubMed ID: 24770409 [No Abstract] [Full Text] [Related]
28. Proliferation activity and apoptosis in granulation tissue and cholesteatoma in middle ear reoperations. Durko M; Kaczmarczyk D Folia Morphol (Warsz); 2004 Feb; 63(1):119-21. PubMed ID: 15039916 [TBL] [Abstract][Full Text] [Related]
29. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma. Kuczkowski J; Bakowska A; Pawelczyk T; Narozny W; Mikaszewski B ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):296-301. PubMed ID: 16825801 [TBL] [Abstract][Full Text] [Related]
30. Re: Is that the ENT SHO? Concerns over training and cross cover. Sharma R; Fu B; Sharp H Clin Otolaryngol; 2010 Feb; 35(1):74. PubMed ID: 20447178 [No Abstract] [Full Text] [Related]
31. Magnetic resonance imaging of cholesteatoma: an update. Vercruysse JP; De Foer B; Somers Th; Casselman J; Offeciers E B-ENT; 2009; 5(4):233-40. PubMed ID: 20163049 [TBL] [Abstract][Full Text] [Related]
33. [Teaching pathology in European countries]. Anichkov NM Arkh Patol; 1992; 54(10):32-4. PubMed ID: 1489264 [TBL] [Abstract][Full Text] [Related]
34. How well is ISCP performing? - an otolaryngologist's overview of the official evaluation report and its executive summary by JCST. Roplekar R; Fu B; Lew-Gor S Clin Otolaryngol; 2013 Jun; 38(3):281-3. PubMed ID: 23745543 [No Abstract] [Full Text] [Related]
35. Autopsy teaching: a dying art? Levison DA Med Teach; 2004 Jun; 26(4):293-4. PubMed ID: 15203838 [No Abstract] [Full Text] [Related]
36. Reducing the follow-up rates over three consecutive specialist registrar trainees placements. Balakumar R; Mirza S Clin Otolaryngol; 2015 Dec; 40(6):715-7. PubMed ID: 25809929 [No Abstract] [Full Text] [Related]
37. [Current concepts of the pathogenesis of acquired middle ear cholesteatoma]. Welkoborsky HJ Laryngorhinootologie; 2011 Jan; 90(1):38-48; quiz 49-50. PubMed ID: 21225533 [TBL] [Abstract][Full Text] [Related]
38. Acquired cholesteatoma epithelial hyperproliferation: Roles of cell proliferation signal pathways. Xie S; Xiang Y; Wang X; Ren H; Yin T; Ren J; Liu W Laryngoscope; 2016 Aug; 126(8):1923-30. PubMed ID: 26989841 [TBL] [Abstract][Full Text] [Related]
39. Experimental cholesteatomas arising from autologous free skin grafting in the middle ear cavity. Hinohira Y; Gyo K; Yanagihara N Acta Otolaryngol; 1994 Sep; 114(5):533-8. PubMed ID: 7825436 [TBL] [Abstract][Full Text] [Related]
40. Methodologies of teaching. The Ethics Committee of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg; 1996 Sep; 115(3):258-61. PubMed ID: 8797788 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]